Induction mortality in all patients, high-risk patients, and sAML patients
| . | CPX-351 . | 7+3 . | . |
|---|---|---|---|
| All patients | n = 85 | n = 41 | |
| 30-d mortality | 3 (3.5) | 3 (7.3) | P = .053 |
| 60-d mortality | 4 (4.7) | 6 (14.6) | |
| High-risk | n = 52 | n = 25 | |
| 30-d mortality | 3 (5.8) | 3 (12.0) | |
| 60-d mortality | 4 (7.7) | 6 (24.0) | |
| sAML | n = 33 | n = 19 | |
| 30-d mortality | 1 (3.0) | 3 (15.8) | |
| 60-d mortality | 2 (6.1) | 6 (31.6) |
| . | CPX-351 . | 7+3 . | . |
|---|---|---|---|
| All patients | n = 85 | n = 41 | |
| 30-d mortality | 3 (3.5) | 3 (7.3) | P = .053 |
| 60-d mortality | 4 (4.7) | 6 (14.6) | |
| High-risk | n = 52 | n = 25 | |
| 30-d mortality | 3 (5.8) | 3 (12.0) | |
| 60-d mortality | 4 (7.7) | 6 (24.0) | |
| sAML | n = 33 | n = 19 | |
| 30-d mortality | 1 (3.0) | 3 (15.8) | |
| 60-d mortality | 2 (6.1) | 6 (31.6) |
Values are n (%) unless otherwise indicated.